Company Overview
About aTyr Pharma
aTyr Pharma is a clinical-stage biopharmaceutical company focused on developing a new class of medicines based on its proprietary tRNA synthetase biology. The company's lead product candidate, efzofitimod, is being evaluated in clinical trials for the treatment of pulmonary sarcoidosis and systemic sclerosis-associated interstitial lung disease.
Frequently Asked Questions about aTyr Pharma
Advertising Pixels
- Facebook Ad Pixel
- LinkedIn Ad Pixel